Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses

Abstract Xenotransplantation (cross-species transplantation) using genetically-engineered pig organs offers a potential solution to address persistent organ shortage. Current evaluation of porcine genetic modifications is to monitor the nonhuman primate immune response and survival after pig organ x...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ping Li, Julia R. Walsh, Kevin Lopez, Abdulkadir Isidan, Wenjun Zhang, Angela M. Chen, William C. Goggins, Nancy G. Higgins, Jianyun Liu, Randy R. Brutkiewicz, Lester J. Smith, Hidetaka Hara, David K. C. Cooper, Burcin Ekser
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3ae22fee438c45fa9103891970992214
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3ae22fee438c45fa9103891970992214
record_format dspace
spelling oai:doaj.org-article:3ae22fee438c45fa91038919709922142021-12-02T18:02:53ZGenetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses10.1038/s41598-021-92543-y2045-2322https://doaj.org/article/3ae22fee438c45fa91038919709922142021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92543-yhttps://doaj.org/toc/2045-2322Abstract Xenotransplantation (cross-species transplantation) using genetically-engineered pig organs offers a potential solution to address persistent organ shortage. Current evaluation of porcine genetic modifications is to monitor the nonhuman primate immune response and survival after pig organ xenotransplantation. This measure is an essential step before clinical xenotransplantation trials, but it is time-consuming, costly, and inefficient with many variables. We developed an efficient approach to quickly examine human-to-pig xeno-immune responses in vitro. A porcine endothelial cell was characterized and immortalized for genetic modification. Five genes including GGTA1, CMAH, β4galNT2, SLA-I α chain, and β2-microglobulin that are responsible for the production of major xenoantigens (αGal, Neu5Gc, Sda, and SLA-I) were sequentially disrupted in immortalized porcine endothelial cells using CRISPR/Cas9 technology. The elimination of αGal, Neu5Gc, Sda, and SLA-I dramatically reduced the antigenicity of the porcine cells, though the cells still retained their ability to provoke human natural killer cell activation. In summary, evaluation of human immune responses to genetically modified porcine cells in vitro provides an efficient method to identify ideal combinations of genetic modifications for improving pig-to-human compatibility, which should accelerate the application of xenotransplantation to humans.Ping LiJulia R. WalshKevin LopezAbdulkadir IsidanWenjun ZhangAngela M. ChenWilliam C. GogginsNancy G. HigginsJianyun LiuRandy R. BrutkiewiczLester J. SmithHidetaka HaraDavid K. C. CooperBurcin EkserNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ping Li
Julia R. Walsh
Kevin Lopez
Abdulkadir Isidan
Wenjun Zhang
Angela M. Chen
William C. Goggins
Nancy G. Higgins
Jianyun Liu
Randy R. Brutkiewicz
Lester J. Smith
Hidetaka Hara
David K. C. Cooper
Burcin Ekser
Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses
description Abstract Xenotransplantation (cross-species transplantation) using genetically-engineered pig organs offers a potential solution to address persistent organ shortage. Current evaluation of porcine genetic modifications is to monitor the nonhuman primate immune response and survival after pig organ xenotransplantation. This measure is an essential step before clinical xenotransplantation trials, but it is time-consuming, costly, and inefficient with many variables. We developed an efficient approach to quickly examine human-to-pig xeno-immune responses in vitro. A porcine endothelial cell was characterized and immortalized for genetic modification. Five genes including GGTA1, CMAH, β4galNT2, SLA-I α chain, and β2-microglobulin that are responsible for the production of major xenoantigens (αGal, Neu5Gc, Sda, and SLA-I) were sequentially disrupted in immortalized porcine endothelial cells using CRISPR/Cas9 technology. The elimination of αGal, Neu5Gc, Sda, and SLA-I dramatically reduced the antigenicity of the porcine cells, though the cells still retained their ability to provoke human natural killer cell activation. In summary, evaluation of human immune responses to genetically modified porcine cells in vitro provides an efficient method to identify ideal combinations of genetic modifications for improving pig-to-human compatibility, which should accelerate the application of xenotransplantation to humans.
format article
author Ping Li
Julia R. Walsh
Kevin Lopez
Abdulkadir Isidan
Wenjun Zhang
Angela M. Chen
William C. Goggins
Nancy G. Higgins
Jianyun Liu
Randy R. Brutkiewicz
Lester J. Smith
Hidetaka Hara
David K. C. Cooper
Burcin Ekser
author_facet Ping Li
Julia R. Walsh
Kevin Lopez
Abdulkadir Isidan
Wenjun Zhang
Angela M. Chen
William C. Goggins
Nancy G. Higgins
Jianyun Liu
Randy R. Brutkiewicz
Lester J. Smith
Hidetaka Hara
David K. C. Cooper
Burcin Ekser
author_sort Ping Li
title Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses
title_short Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses
title_full Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses
title_fullStr Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses
title_full_unstemmed Genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses
title_sort genetic engineering of porcine endothelial cell lines for evaluation of human-to-pig xenoreactive immune responses
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3ae22fee438c45fa9103891970992214
work_keys_str_mv AT pingli geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses
AT juliarwalsh geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses
AT kevinlopez geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses
AT abdulkadirisidan geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses
AT wenjunzhang geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses
AT angelamchen geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses
AT williamcgoggins geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses
AT nancyghiggins geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses
AT jianyunliu geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses
AT randyrbrutkiewicz geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses
AT lesterjsmith geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses
AT hidetakahara geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses
AT davidkccooper geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses
AT burcinekser geneticengineeringofporcineendothelialcelllinesforevaluationofhumantopigxenoreactiveimmuneresponses
_version_ 1718378860817416192